Franklin Genomic Advancements ETF Rating $26.94 -0.19 (-0.70%) Closing price 05/1/2025 03:52 PM EasternExtended Trading$26.91 -0.02 (-0.09%) As of 05/1/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.77Holdings in HELX have an aggregate rating of Moderate Buy based on 642 analyst ratings issued in the past year covering 45 companies (84.1% of the portfolio).HELX Aggregate Price Target$26.94High Prediction$26.94Average Prediction$26.94Low Prediction$26.94Holdings in HELX have an aggregate price target of $26.94 and a range of $26.94 to $26.94 covering 45 companies (84.1% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 HELX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.02%NTRANatera$151.36+0.3%2.8707 of 5 stars3.00$175.76 16.1%16Upcoming EarningsInsider TradePositive News5.08%VRTXVertex Pharmaceuticals$498.86-2.1%3.9499 of 5 stars2.64$514.91 3.2%25Upcoming EarningsPositive News4.82%KRYSKrystal Biotech$165.69-2.5%4.905 of 5 stars3.00$222.71 34.4%8Upcoming EarningsAnalyst RevisionNews CoveragePositive News3.64%LLYEli Lilly and Company$794.67-11.6%4.9837 of 5 stars2.80$1,000.32 25.9%20Earnings ReportAnalyst ForecastGap DownHigh Trading Volume3.56%REGNRegeneron Pharmaceuticals$590.00-1.5%4.8231 of 5 stars2.88$892.60 51.3%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision3.48%MEDPMedpace$302.25-2.0%4.4027 of 5 stars2.23$349.30 15.6%13Short Interest ↑3.31%BNTXBioNTech$102.43-1.7%2.5443 of 5 stars2.89$143.44 40.0%18Upcoming EarningsGap Up2.88%TMOThermo Fisher Scientific$419.88-2.1%4.8524 of 5 stars2.81$607.43 44.7%21Analyst ForecastInsider TradeShort Interest ↑2.83%AZNAstraZeneca$70.51-1.8%2.8818 of 5 stars3.10$88.00 24.8%10Earnings ReportShort Interest ↓Analyst RevisionGap Down2.81%CTVACorteva$62.08+0.2%4.1467 of 5 stars2.72$68.13 9.7%18Dividend AnnouncementPositive News2.50%UTHRUnited Therapeutics$293.85-3.0%4.9851 of 5 stars2.67$392.00 33.4%12Earnings ReportAnalyst ForecastPositive News2.47%ALNYAlnylam Pharmaceuticals$255.13-3.1%4.2067 of 5 stars2.77$315.58 23.7%26Earnings ReportAnalyst DowngradeGap Down2.32%INSMInsmed$72.64+0.9%4.3678 of 5 stars3.00$94.00 29.4%16Upcoming EarningsPositive News2.23%GHGuardant Health$48.87+3.5%4.068 of 5 stars3.05$51.64 5.7%22Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap UpHigh Trading Volume2.20%TWSTTwist Bioscience$37.71-1.6%3.6136 of 5 stars2.70$52.80 40.0%10Upcoming EarningsPositive News2.14%CDNSCadence Design Systems$299.73+0.7%4.3469 of 5 stars2.77$322.54 7.6%13Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage2.01%RAREUltragenyx Pharmaceutical$38.970.0%4.3586 of 5 stars2.93$92.79 138.1%14Upcoming EarningsShort Interest ↑Positive News1.91%DHRDanaher$196.90-1.2%4.9071 of 5 stars2.80$264.40 34.3%20Insider TradeShort Interest ↑1.80%RVTYRevvity$92.95-0.5%3.7307 of 5 stars2.80$125.64 35.2%15Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.69%BBIOBridgeBio Pharma$38.40+0.1%4.5565 of 5 stars2.92$57.09 48.7%12Earnings ReportAnalyst ForecastNews CoverageHigh Trading Volume1.63%QGENQiagen$42.22-1.2%3.6842 of 5 stars2.30$48.42 14.7%10Upcoming Earnings1.61%EXASExact Sciences$47.16+3.3%4.4909 of 5 stars2.95$69.25 46.8%221.57%LGNDLigand Pharmaceuticals$109.15-0.6%4.4069 of 5 stars3.00$146.43 34.2%7Upcoming EarningsPositive News1.42%RGENRepligen$137.20-0.6%4.8524 of 5 stars2.64$173.25 26.3%14Earnings ReportAnalyst UpgradeAnalyst RevisionNews CoveragePositive News1.22%LHLaboratory Co. of America$241.26+0.1%4.7226 of 5 stars2.87$267.85 11.0%15Earnings ReportAnalyst ForecastShort Interest ↑1.21%AAgilent Technologies$106.46-1.1%4.7283 of 5 stars2.46$143.00 34.3%13Positive News1.19%TEMTempus AI$51.85+0.3%2.3796 of 5 stars2.54$61.08 17.8%13Upcoming EarningsGap Up1.14%ADPTAdaptive Biotechnologies$7.364.1249 of 5 stars3.00$9.40 27.7%5Earnings ReportNews CoveragePositive News1.13%BMRNBioMarin Pharmaceutical$62.71-1.5%4.9205 of 5 stars2.70$93.14 48.5%23Positive News1.03%CRLCharles River Laboratories International$116.92-1.4%4.8168 of 5 stars1.94$182.00 55.7%16Upcoming EarningsPositive News1.00%NBIXNeurocrine Biosciences$106.59-1.0%4.8702 of 5 stars2.86$160.90 51.0%22Upcoming Earnings0.88%RXRXRecursion Pharmaceuticals$5.50-1.6%2.2134 of 5 stars2.33$8.20 49.1%6Upcoming EarningsGap Up0.86%IQVIQVIA$151.02-2.6%4.9574 of 5 stars2.75$237.62 57.3%24Upcoming Earnings0.84%VCYTVeracyte$29.71-2.6%3.9648 of 5 stars2.70$42.60 43.4%10Upcoming EarningsShort Interest ↑Positive News0.84%DOCSDoximity$58.11+2.2%3.2471 of 5 stars2.57$65.39 12.5%21Positive News0.84%BEAMBeam Therapeutics$19.83-0.5%3.0896 of 5 stars3.00$49.45 149.4%14Upcoming EarningsShort Interest ↑News Coverage0.79%GRALGrail$32.49-5.8%0.6998 of 5 stars2.25$26.00 -20.0%4Positive News0.78%TECHBio-Techne$49.63-1.4%4.8815 of 5 stars2.38$81.14 63.5%8Upcoming EarningsPositive News0.75%SRPTSarepta Therapeutics$62.78+0.6%4.745 of 5 stars2.83$158.70 152.8%24Upcoming Earnings0.69%DVAXDynavax Technologies$11.48-2.3%4.3668 of 5 stars2.33$20.50 78.6%3Upcoming Earnings0.66%BIOBio-Rad Laboratories$240.28-1.6%4.4099 of 5 stars2.60$380.20 58.2%5Earnings ReportShort Interest ↑News CoveragePositive News0.63%AZTAAzenta$26.23-0.4%3.4719 of 5 stars2.50$57.00 117.3%4Upcoming EarningsPositive News0.58%SDGRSchrödinger$24.88-2.9%2.4635 of 5 stars3.00$32.80 31.8%60.57%WGSGeneDx$62.32-6.8%3.5785 of 5 stars2.57$78.14 25.4%7Earnings ReportAnalyst ForecastInsider TradePositive NewsGap UpHigh Trading Volume0.55%BRKRBruker$39.35-1.8%4.983 of 5 stars2.55$65.00 65.2%11Upcoming EarningsShort Interest ↓Positive News This page (BATS:HELX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
